Nektar

2014 Looking Like A Big Year For Nektar
Seeking Alpha
Mon, 12/30/13 - 10:16 am
Nektar
NKTR-118
NKTR-102
3 Biotechs That Could Double In 2014
Seeking Alpha
Thu, 12/26/13 - 09:43 am
Nektar
Inovio
Arena Pharmaceuticals
2014 FDA Drug Approval Decision Calendar
TheStreet.com
Wed, 11/27/13 - 08:39 am
FDA
drug approvals
GSK
Gilead
Theravance
Auxilium
Amarin
Bristol-Myers Squibb
Biogen Idec
Pozen
Vanda
Chelsea Therapeutics
pSivida
Alimera
United Therapeutics
Biomarin
JNJ
Pharmacyclics
Celgene
MannKind
Santarus
AstraZeneca
Durata Therapeutics
Eli Lilly
Omeros
BioDelivery Sciences
Anacor
Keryx
Cubist Pharmaceuticals
Nektar
3 Companies That Could Make You a Successful Clinical-Stage Biotech Investor
Motley Fool
Sun, 09/29/13 - 01:23 pm
Gilead Sciences
Isis Pharmaceuticals
Nektar
Nektar's Pain Drug Disappoints
Yahoo/Zacks
Sat, 09/28/13 - 12:15 pm
pain management
NKTR-181
Nektar
Nektar Plummets After Pain Drug Misses Goals of Mid-Stage Study
Bloomberg
Fri, 09/27/13 - 11:41 am
Nektar
NKTR-181
chronic pain
Rough market day for Nektar, while Pharmacyclics and Regeneron soar
Marketwatch
Fri, 09/27/13 - 08:37 am
Nektar
Pharmacyclics
Regeneron
osteoarthritis
NKTR-181
ibrutinib
This Week in Biotech
Motley Fool
Sun, 06/23/13 - 11:11 am
Nektar
NKTR-181
pain management
Novartis
serelaxin
Idenix
IDX20963
hepatitis C
ViroPharma
JNJ
Aragon
ARN-509
prostage cancer
Nektar Therapeutics Gains on Trial of New Painkiller
Bloomberg
Wed, 06/19/13 - 04:01 pm
Nektar
NKTR-181
abuse-resistant painkillers
Nektar Posts Wider Loss, Maintains View
Yahoo/Zacks
Wed, 05/15/13 - 02:52 pm
earnings
Nektar
Nektar Therapeutics Increases Sales but Misses Estimates on Earnings
Motley Fool
Sat, 05/11/13 - 11:08 am
Nektar
earnings
Why AstraZeneca Will Disappoint In 2013
Seeking Alpha
Mon, 03/18/13 - 10:51 am
AstraZeneca
AbbVie
Bristol-Myers Squibb
Merck
Pfizer
Nektar
3 Things to Watch With Nektar Therapeutics
Motley Fool
Mon, 11/19/12 - 01:55 pm
Nektar
Naloxegol
AstraZeneca
This Week in Biotech: Part 2
Motley Fool
Sat, 11/17/12 - 01:49 pm
Clovis Oncology
Eli Lilly
Celgene
Nektar
AstraZeneca
Salix
Progenics Pharmaceuticals
Dynavax Technologies
Tranzyme
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 11/17/12 - 01:36 pm
Clovis Oncology
Dynavax Technologies
Nektar
Why Nektar Therapeutics' Shares Tumbled
Motley Fool
Tue, 11/13/12 - 12:09 pm
Nektar
AstraZeneca
Naloxegol
Here's Why Nektar Therapeutics's Latest Report Might Worry You
Motley Fool
Thu, 10/11/12 - 05:48 pm
Nektar
Four Important Biotech Stocks Targeting Unmet Needs
Motley Fool
Tue, 09/4/12 - 11:08 am
Neurocrine Biosciences
Acorda Therapeutics
Amarin
Nektar
3 Reasons Pfizer Should Partner With MannKind
Motley Fool
Fri, 08/24/12 - 11:01 am
Pfizer
MannKind
inhaled insulin
diabetes
Nektar
Afrezza
Exubera
8 Intriguing Small Cap Biotechnology Companies For Your Consideration
Seeking Alpha
Mon, 08/20/12 - 10:32 am
Affymax
Alnylam
Arena Pharmaceuticals
Aveo
BioTime
ChemoCentryx
Emergent BioSolutions
Clovis Oncology
Enzon
Forest Labs
Geron
ViroPharma
Targacept
GSK
Pfizer
Santarus
PDL Biopharma
Infinity Pharmaceuticals
Nektar

Pages